Hyundai Pharm (004310) — Cash Flow Quality Index
Latest as of May 2026:
1.97x
Hyundai Pharm (004310) has a Cash Flow Quality Index of 1.97x as of May 2026. Operating cash flow of ₩2.39 Billion exceeds net income of ₩1.21 Billion, indicating high earnings quality where cash backs reported profits. Explore Hyundai Pharm cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.97x
Operating CF / Net Income
Operating Cash Flow
₩2.39 Billion
KRW
Net Income
₩1.21 Billion
KRW
Data as of
May 2026
Most recent filing
Hyundai Pharm Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Hyundai Pharm across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Hyundai Pharm cash flow conversion.
Annual Cash Flow Quality Index for Hyundai Pharm (2010–2025)
Year-by-year earnings quality comparison for Hyundai Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.05x | ₩-123.29 Million | ₩2.52 Billion | ▲ +93.4% |
| 2023 | -0.74x | ₩-4.55 Billion | ₩6.12 Billion | ▼ -115.0% |
| 2020 | 4.94x | ₩10.80 Billion | ₩2.19 Billion | ▼ -17.8% |
| 2019 | 6.01x | ₩6.96 Billion | ₩1.16 Billion | ▲ +97.0% |
| 2018 | 3.05x | ₩2.83 Billion | ₩928.94 Million | ▲ +324.6% |
| 2017 | -1.36x | ₩-1.98 Billion | ₩1.46 Billion | ▲ +37.6% |
| 2016 | -2.18x | ₩-2.75 Billion | ₩1.26 Billion | ▼ -138.8% |
| 2013 | 5.62x | ₩7.95 Billion | ₩1.41 Billion | ▼ -53.4% |
| 2011 | 12.05x | ₩6.27 Billion | ₩520.10 Million | ▲ +1235.5% |
| 2010 | 0.90x | ₩2.68 Billion | ₩2.97 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.